Erwinase Study in Patients With Acute Lymphoblastic Leukemia

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Leukemia
Interventions
DRUG

Erwinase

If allergic to E.Coli Asparaginase = 1 Dose (20,000 Units/m\^2) Daily; If allergic to Pegylated Asparaginase = 6 Doses (25,000 Units/m\^2) Daily Every Other Day. Received as an injection through a needle in vein, under the skin, or in muscle.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00506597 - Erwinase Study in Patients With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter